Home NDC 50090-0754-0 Viread
Product NDC 50090-0754
Requested package NDC 50090-0754-0
11-digit product format 500900754
Labeler code 50090
Product ID 50090-0754_ffa93c8c-b423-4326-baea-d60e37882173
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name TENOFOVIR DISOPROXIL FUMARATE
Dosage form TABLET, COATED
Route ORAL
Labeler A-S Medication Solutions
Application NDA021356
Marketing category NDA
Marketing start 2001-10-26
Marketing end 0000-00-00
Substance TENOFOVIR DISOPROXIL FUMARATE
Active strength 300 mg/1
Pharmacologic classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021356-001 VIREAD TENOFOVIR DISOPROXIL FUMARATE 300MG TABLET / ORAL AB RLD, RS 2001-10-26 N021356-002 VIREAD TENOFOVIR DISOPROXIL FUMARATE 150MG TABLET / ORAL AB RLD 2012-01-18 N021356-003 VIREAD TENOFOVIR DISOPROXIL FUMARATE 200MG TABLET / ORAL AB RLD 2012-01-18 N021356-004 VIREAD TENOFOVIR DISOPROXIL FUMARATE 250MG TABLET / ORAL AB RLD 2012-01-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021356-001 VIREAD 300MG TABLET / ORAL AB RLD, RS 2001-10-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021356-002 VIREAD 150MG TABLET / ORAL AB RLD 2012-01-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021356-003 VIREAD 200MG TABLET / ORAL AB RLD 2012-01-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021356-004 VIREAD 250MG TABLET / ORAL AB RLD 2012-01-18 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 164 observed states.
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 108 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Viread TENOFOVIR DISOPROXIL FUMARATE Gilead Sciences, Inc. 33fd6418-fbdc-42ca-a50d-ce2a476a5418 2025-02-18 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 021356 application number: NDA021356
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 50090-0754-0 50090075400 30 TABLET, COATED in 1 BOTTLE, PLASTIC (50090-0754-0) 2014-11-28 0000-00-00 No No Current